Albumedix - Dedicated to Better Health

Albumedix is a science-driven, life-science company focused on enabling the creation of advanced therapies and biopharmaceuticals utilizing our high quality recombinant human albumin products and technologies. We believe in empowering excellence to enable advanced therapies and facilitate otherwise unstable drug candidates reach patients worldwide. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical and medical device companies worldwide. Headquartered in Nottingham, England with more than 100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started more than 35 years ago.

Our vision is to empower excellence in how we as a business operate and create products and services of the highest quality; but also to enable our customers and partners to excel in the development of transformative therapies, and thereby support life sciences and patients equally. As an example, we are proud to be working with domestic, national and international life science companies in these challenging times towards the urgent response against covid-19 - be it diagnostically, therapeutically and prophylactically.

Company type
Brian MacDonald
LinkedIn logo Head of Business Development 

Barrington James

Barrington James is a leading global Life Science industry search company. With multiple offices in three continents (Europe, North America and Asia) we maintain international networks and reach for board and executive appointments in the sector. All of our team are dedicated market specialists with unrivalled candidate networks to provide the assistance you may need to aid you getting your product to market. We have proven experience in knowing the difference between working for a big pharma and a new start-up Biotech and will ensure that the people you hire truly understand your business and what you need to succeed.

Company type
James Lewis
LinkedIn logo Executive Director 

BioPartner UK

BioPartner UK leads the UK Delegation to several partnering conferences 
each year. It is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with UK based Life Sciences organisations.

BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting to UK expertise.

BioPartner has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and
 in partnership with the UK government. BioPartner helps UK-based SMEs exhibit their services and products in new overseas markets.

Lin Bateson
Lin Bateson
LinkedIn logo Chief Executive 

Evgen Pharma Plc

Evgen Pharma is an AIM listed clinical stage drug development company developing medicines for the treatment of multiple diseases focusing on Oncology.
Our lead programme has completed a study in patients with oestrogen-positive (ER+) metastatic breast cancer and will be entering a Ph2 study in Glioma patients (Glioblastoma multiforme) in H2 2022.
We are open to partnering discussions as well as in-licensing/acquisition opportunities in cancer therapeutics and supportive care.

Company type
Dr Helen Kuhlman
LinkedIn logo Chief Business Officer 
Dr Huw Jones
LinkedIn logo Chief Executive Officer 

Karma Oncology

Karma Oncology is a specialised oncology clinical development company headquartered in Scotland with offices in Netherlands and USA.  We offer a complete range of development services from clinical development planning, protocol design and authoring, strategic country/site selection, regulatory submissions, through to clinical trial execution and reporting. 

Adaptable - We can provide selected individual services, and extend to full-service global CRO capabilities clients require.  Our size allows us to be flexible, innovative and responsive to individual sponsor requirements and to adhere strictly to sponsor specified development timelines.

Reliable - Our Project Managers have extensive oncology experience, our monitors are professional, mature 'career' CRAs - not trainees - and we have the lowest staff turnover in the industry (<5%).  Many of our staff come from a nursing or medical background, and for international studies we use CRAs native to their country.

Motivated - Our team has successfully completed programs in a broad range of solid tumour and hematologic indications utilising an array of different therapeutic approaches including immunotherapy and cell therapies (autologous, CAR-T and CAR-NK).

Accountable – The Karma team focus on delivering quality while respecting sponsor timelines (not internal timelines) and will do what it takes to do so.

Twitter Account @KarmaOncology
Dr Karen J. Williams
LinkedIn logo CEO 

National Institute for Health Research (NIHR)

We are the Clinical Research Network (CRN) part of the National Institute for Health Research (NIHR). From feasibility, to site selection, to monitoring recruitment. We provide the life sciences industry with a flexible package of free support to help plan, place and successfully deliver clinical research in the UK to time and target. We do this by working in partnership with the NHS and social care providers to deliver high quality commercial clinical research. Our dedicated, research-ready workforce of 10,000+ personnel is embedded throughout our health and care services in England. Our support is available to all life science industries regardless of location, study type, study size, or therapy area.

Dr Natalie Wilson
LinkedIn logo Dr Natalie Wilson Business Development Manager  
Karen Mathews
LinkedIn logo Business Development Manager 

Oxford Biomedica

Company type


Company type

Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.

We employ over 900 staff and operate from state-of-the-art manufacturing and clinical facilities in the US and UK. Our people make Quotient Sciences a special place to work. We are a dedicated team passionate about innovating and transforming drug development to help our customers develop new medicines for patients in need.

We recruit people that are committed to making a difference, who excel at customer service and are always willing to go the extra mile. Teamwork is integral to our culture and success — helping, supporting and mentoring run through our DNA. Expect to join an empowering and innovative culture, where we encourage continuous improvement and offer opportunities to learn and develop every day.

Dr Asma Patel
LinkedIn logo Vice President of Integrated Development Services, Early Development 


Company type